Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Healthcare Associated Infections II: Preventive Measures

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026

Same author

Distinct Metabolic Signatures Linked to High-Resolution Computed Tomography Radiographic Phenotypes in Stable and Progressive Fibrotic Lung Disease.

Metabolites·2026

Same author

Severe community-acquired pneumonia: current concepts and controversies.

Intensive care medicine·2026

Same author

Metabolomic profiling reveals distinct lipid signatures in progressive versus stable fibrotic lung disease.

Metabolomics : Official journal of the Metabolomic Society·2025

Same author

The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae.

Current opinion in infectious diseases·2024

Same author

Clarithromycin for improved clinical outcomes in community-acquired pneumonia: A subgroup analysis of the ACCESS trial.

International journal of antimicrobial agents·2024

Search research articles

Related Experiment Video

Updated: May 10, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Nosocomial pneumonia: lessons learned.

Girish B Nair¹, Michael S Niederman

¹Pulmonary and Critical Care Medicine, Winthrop-University Hospital, Mineola, NY 11501, USA.

Critical Care Clinics

|July 9, 2013

Summary

This summary is machine-generated.

Nosocomial pneumonia, a hospital-acquired infection, presents diverse risks and diagnostic challenges. This review explores its prevention and treatment, considering varying patient populations and pathogens.

Keywords:

Antimicrobial treatment Health care–associated pneumonia Hospital-acquired pneumonia Nosocomial pneumonia Prevention Ventilator-associated complications Ventilator-associated pneumonia

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Experiment Videos

Last Updated: May 10, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Area of Science:

Infectious Diseases
Pulmonology
Critical Care Medicine

Background:

Nosocomial pneumonia is a major hospital-acquired infection with significant global economic impact.
Healthcare-associated pneumonia (HCAP) patients are a heterogeneous group, not all at risk for typical nosocomial pathogens.
Some HCAP cases involve organisms similar to community-acquired pneumonia.

Purpose of the Study:

To review risk factors for nosocomial pneumonia.
To discuss diagnostic controversies in nosocomial pneumonia.
To outline treatment and prevention strategies for nosocomial and HCAP.

Main Methods:

Literature review of nosocomial pneumonia.
Analysis of risk factors, diagnostic methods, and treatment/prevention strategies.
Synthesis of current understanding of HCAP.

Main Results:

Nosocomial pneumonia risk factors vary, necessitating tailored prevention.
Diagnosis can be challenging due to overlapping pathogens with community-acquired pneumonia.
Effective management requires differentiating patient risk and causative agents.

Conclusions:

Understanding patient heterogeneity is key to preventing nosocomial pneumonia.
Standardized diagnostic criteria and targeted therapies are crucial.
Multifaceted approaches are needed for effective treatment and prevention.